Windtree Therapeutics, Inc. (WINT) Financials

WINT Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 36.1 million 28.6 million
2023-06-30 40.6 million 29.0 million
2023-03-31 35.2 million 28.2 million
2022-12-31 38.0 million 27.9 million

WINT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.9 million 305000
2023-06-30 -3.5 million 382000
2023-03-31 -2.5 million 285000
2022-12-31 -3.4 million 791000

WINT Net Income

No data available :(

WINT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 7.4 million - 1.7 million
2023-06-30 11.5 million - 1.8 million
2023-03-31 4.2 million - 1.9 million
2022-12-31 6.2 million - 2.0 million

WINT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 5.1 million
2023-06-30 4.0 million
2023-03-31 863000
2022-12-31 745000

WINT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 15000 2.1 million 2.6 million -
2023-06-30 - 1.8 million 2.4 million -
2023-03-31 - 1.4 million 2.3 million -
2022-12-31 - 1.2 million 2.2 million -

WINT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 14000
2023-06-30 - 120000
2023-03-31 - 139000
2022-12-31 - 135000

WINT

Price: $4.40

52 week price:
0.28
7.79

Earnings Per Share: -16.79 USD

P/E Ratio: -0.02

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 214600

Market Capitalization: 3.9 million

Links: